AMERIPRISE FINANCIAL INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AMERIPRISE FINANCIAL INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.91B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $17.93B | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $16.10B | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $14.33B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $13.39B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $11.96B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $13.10B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $12.92B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $12.18B | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $11.84B | Feb 27, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.56B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $3.40B | Mar 12, 2026 |
| FY2023 | Dec 31, 2023 | $377.00M | Feb 22, 2024 |
| FY2023 | Sep 30, 2023 | $872.00M | Feb 22, 2024 |
| FY2023 | Jun 30, 2023 | $890.00M | Feb 22, 2024 |
| FY2023 | Mar 31, 2023 | $417.00M | Feb 22, 2024 |
| FY2023 | Dec 31, 2022 | $649.00M | Feb 22, 2024 |
| FY2023 | Sep 30, 2022 | $1.06B | Feb 22, 2024 |
| FY2023 | Jun 30, 2022 | $614.00M | Feb 22, 2024 |
| FY2023 | Mar 31, 2022 | $825.00M | Feb 22, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.32B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $6.60B | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $4.69B | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $4.41B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $3.33B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $4.62B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $2.34B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $2.60B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $1.52B | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $2.33B | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $190.90B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $181.40B | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $175.19B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $158.85B | Feb 22, 2024 |
| FY2023 | Dec 31, 2021 | $177.74B | Feb 22, 2024 |
| FY2021 | Dec 31, 2020 | $165.88B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $151.83B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $137.22B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $147.48B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $139.82B | Feb 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $184.36B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $176.18B | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $170.46B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $155.05B | Feb 22, 2024 |
| FY2023 | Dec 31, 2021 | $172.90B | Feb 22, 2024 |
| FY2021 | Dec 31, 2020 | $160.02B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $146.10B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $131.63B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $141.49B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $133.53B | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.55B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $5.23B | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $4.73B | Mar 12, 2026 |
| FY2025 | Dec 31, 2022 | $3.80B | Mar 12, 2026 |
| FY2024 | Dec 31, 2021 | $4.84B | Feb 20, 2025 |
| FY2023 | Dec 31, 2020 | $6.13B | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | $5.91B | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $5.59B | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $6.00B | Feb 24, 2021 |
| FY2019 | Dec 31, 2016 | $6.29B | Feb 26, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.44B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.40B | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.41B | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $1.39B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.46B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.18B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.17B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.16B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $1.18B | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $1.10B | Feb 27, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.66B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $24.71B | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $21.91B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $19.92B | Feb 22, 2024 |
| FY2023 | Dec 31, 2021 | $17.32B | Feb 22, 2024 |
| FY2021 | Dec 31, 2020 | $15.29B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $14.28B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $12.91B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $11.33B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $10.35B | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $2.32B | Feb 23, 2017 |
| FY2016 | Dec 31, 2015 | $2.36B | Feb 23, 2017 |
| FY2016 | Dec 31, 2014 | $2.64B | Feb 23, 2017 |
| FY2016 | Dec 31, 2013 | $2.63B | Feb 23, 2017 |
| FY2015 | Dec 31, 2012 | $2.37B | Feb 25, 2016 |
| FY2014 | Dec 31, 2011 | $2.78B | Feb 24, 2015 |
| FY2013 | Dec 31, 2010 | $2.86B | Feb 27, 2014 |
| FY2012 | Dec 31, 2009 | $3.10B | Feb 27, 2013 |
| FY2011 | Dec 31, 2008 | $6.23B | Feb 24, 2012 |
| FY2009 | Dec 31, 2007 | $3.84B | Feb 24, 2010 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2009 | Dec 31, 2009 | $2.25B | Feb 24, 2010 |
| FY2009 | Dec 31, 2008 | $2.03B | Feb 24, 2010 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 36 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 33 | Mar 12, 2026 |
| FY2023 | Dec 31, 2023 | 3 | Feb 22, 2024 |
| FY2023 | Sep 30, 2023 | 8 | Feb 22, 2024 |
| FY2023 | Jun 30, 2023 | 8 | Feb 22, 2024 |
| FY2023 | Mar 31, 2023 | 3 | Feb 22, 2024 |
| FY2023 | Dec 31, 2022 | 5 | Feb 22, 2024 |
| FY2023 | Sep 30, 2022 | 9 | Feb 22, 2024 |
| FY2023 | Jun 30, 2022 | 5 | Feb 22, 2024 |
| FY2023 | Mar 31, 2022 | 7 | Feb 22, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 36 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 33 | Mar 12, 2026 |
| FY2023 | Dec 31, 2023 | 3 | Feb 22, 2024 |
| FY2023 | Sep 30, 2023 | 8 | Feb 22, 2024 |
| FY2023 | Jun 30, 2023 | 8 | Feb 22, 2024 |
| FY2023 | Mar 31, 2023 | 3 | Feb 22, 2024 |
| FY2023 | Dec 31, 2022 | 5 | Feb 22, 2024 |
| FY2023 | Sep 30, 2022 | 9 | Feb 22, 2024 |
| FY2023 | Jun 30, 2022 | 5 | Feb 22, 2024 |
| FY2023 | Mar 31, 2022 | 7 | Feb 22, 2024 |